|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
AVI Biopharma Axes 28% of Workforce, After Missing Out on Flu Contract
|
Luke Timmerman |
12/12/11 |
Seattle
|
|
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company
|
Luke Timmerman |
06/02/11 |
Seattle
|
|
Shire Finds Big Value in Rare Diseases, and a Strong Growth Path for its Boston Unit
|
Arlene Weintraub |
05/12/11 |
New York
|
|
Acceleron Pharma Cuts 40 Percent of Workforce
|
Luke Timmerman |
11/03/10 |
Boston
|
|
Acceleron Weans Itself Off VC, Continues its Roll with Pharma Partner Dollars
|
Ryan McBride |
09/28/10 |
Boston
|
|
Genzyme Sheds Testing Unit, Red Bend Acquires VirtualLogix, Acceleron Forges Alliance with Shire, & More Boston-Area Deals News
|
Rebecca Zacks |
09/15/10 |
Boston
|
|
Acceleron Snags $498M Deal With Shire to Develop Muscular Dystrophy Drugs
|
Luke Timmerman |
09/09/10 |
Boston
|
|
Genentech Inks Antibody Deal, Cytokinetics Sticks With Science First, BioMarin Scraps Drug, & More Bay Area Life Sciences News
|
Luke Timmerman |
08/06/10 |
San Francisco
|
|
BioMarin Scraps Muscular Dystrophy Drug
|
Luke Timmerman |
08/02/10 |
San Francisco
|
|
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/22/10 |
Seattle
|
|
Cell Therapeutics Nears Judgment Day, AVI Biopharma Awaits Results, HemaQuest Gets $6M & More Seattle-Area Life Sciences News
|
Luke Timmerman |
02/04/10 |
Seattle
|
|
AVI Nails Down $30M
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/06/09 |
Seattle
|
|
AVI Biopharma Bolts from Portland to Seattle to Tap Biotech Talent
|
Luke Timmerman |
07/30/09 |
Seattle
|
|
Dendreon’s Former Boss Predicts Takeover, Covance Buys Merck Lab, How NanoString Got $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/30/09 |
Seattle
|
|
AVI Gets Duchenne Funding
|
Luke Timmerman |
07/28/09 |
Seattle
|
|
Dendreon Resists Urge to Sell Out, NanoString Nabs $30M, VC Firm Cashes Out on OncoGenex, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
06/11/09 |
Seattle
|
|
AVI Gets $3M For Muscular Dystrophy
|
Luke Timmerman |
06/04/09 |
Seattle
|
|
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/07/09 |
Seattle
|
|
AVI Biopharma Out to Reinvent Itself, Making RNA-based Drugs for Ebola and Other Nasty Things
|
Luke Timmerman |
09/10/08 |
Seattle
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
